1. Home
  2. CGEM vs FSBC Comparison

CGEM vs FSBC Comparison

Compare CGEM & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$16.35

Market Cap

904.7M

Sector

Health Care

ML Signal

HOLD

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$42.47

Market Cap

860.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
FSBC
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
904.7M
860.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CGEM
FSBC
Price
$16.35
$42.47
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$30.13
$41.90
AVG Volume (30 Days)
956.5K
70.3K
Earning Date
05-11-2026
04-27-2026
Dividend Yield
N/A
2.47%
EPS Growth
N/A
28.32
EPS
N/A
0.87
Revenue
N/A
N/A
Revenue This Year
N/A
$30.25
Revenue Next Year
$5.20
$12.30
P/E Ratio
N/A
$48.55
Revenue Growth
N/A
N/A
52 Week Low
$5.68
$26.26
52 Week High
$16.74
$42.74

Technical Indicators

Market Signals
Indicator
CGEM
FSBC
Relative Strength Index (RSI) 62.01 63.48
Support Level $11.92 $39.93
Resistance Level N/A N/A
Average True Range (ATR) 1.03 0.95
MACD 0.08 0.08
Stochastic Oscillator 89.05 90.52

Price Performance

Historical Comparison
CGEM
FSBC

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.

Share on Social Networks: